We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Getein Biotech, Inc.

Getein Biotech, Inc. is a fully integrated in vitro diagnostic company that develops, manufactures and distributes an... read more Featured Products: More products

Download Mobile App





Getein Biotech Exhibits Advanced POCT Analyzers

By LabMedica International staff writers
Posted on 13 Nov 2023
Print article
Image: The Metis 6000 Modular System is being highlighted at MEDICA 2023 (Photo courtesy of Getein)
Image: The Metis 6000 Modular System is being highlighted at MEDICA 2023 (Photo courtesy of Getein)

Getein Biotech, Inc. (Nanjing, China) is exhibiting its range of advanced analyzers for point-of-care testing at MEDICA 2023.

At the MEDICA show, visitors to the Getein booth can experience its unique products and services first-hand that deliver efficient diagnostic and treatment solutions, helping healthcare professionals increase efficiency, reduce costs, and deliver a better patient experience. Getein is highlighting its Metis 6000 Modular System (Integrated Clinical Chemistry and Immunochemistry) that helps labs unlock efficiency and optimize space. The Metis 6000 Modular System comprises the MAGICL 6200 immunochemistry module with a throughput of up to 400 T/H, the CM-1000 clinical chemistry module with a throughput of up to 1000 T/H, and the SHC 200 pre-analytical module (optional) with a speed of 190 tubes/H.

Getein is also showcasing the Metis 600 Modular System (Integrated Immunofluorescence and Hematology) which provides a suitable solution for immunofluorescence and hematology testing in low-volume laboratories. The Metis 600 Modular System comprises the Getein 1200 immunofluorescence quantitative analyzer and the BHA-5100 automatic hematology analyzer. The combination of immunofluorescence and hematology methodologies allows for more comprehensive test items to be offered. Also on display at MEDICA 2023 is the BHA-5000 automatic 5-part differential hematology analyzer which uses laser-based flow cytometry to count white blood cells in blood samples. It also uses electrical impedance to count red blood cells and platelets, and colorimetry to measure the hemoglobin, and relevant parameters will be enumerated.

In addition, Getein is exhibiting the MAGICL 6000 chemiluminescence immunoassay analyzer designed for mid to high-workflow laboratories that require a one-step chemiluminescence solution. Alongside MAGICL 6000 was the Getein 1600 fully-automated immunofluorescence quantitative analyzer which combined with bar-coded, ready-to-use strip cassettes, delivers accurate testing results in minutes. The company is demonstrating the Getein 208 hand-held integrated system which is intended to detect and quantify specific chemical components in human blood serum, plasma, whole blood, capillary blood, and urine samples through dry chemistry and fluorescence immunoassay. Visitors to the company’s booth can learn about Getein’s POCT test menu which includes a wide range of reagent options, covering rapid testing for various diseases and health indicators.

Related Links:
Getein Biotech, Inc. 

New
Gold Member
Rotavirus Test
Rotavirus Test - 30003 – 30073
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Centrifuge
Hematocrit Centrifuge 7511M4
New
Community-Acquired Pneumonia Test
RIDA UNITY CAP Bac

Print article

Channels

Clinical Chemistry

view channel
Image: The study demonstrated that electric-field molecular fingerprinting can probe cancer (Photo courtesy of ACS Central Science, 2025, 10.1021/acscentsci.4c02164)

New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma

Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read more

Molecular Diagnostics

view channel
Image: The study validated the Lumipulse p-tau21 automated and scalable blood test system (Photo courtesy of Fujirebio)

Blood Test for Early Alzheimer's Detection Achieves Over 90% Accuracy

Alzheimer's disease (AD) is a debilitating condition and a leading cause of disability and death worldwide. The availability of reliable diagnostic tools is currently restricted, and diagnosis often relies... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.